Results 41 to 50 of about 2,778 (118)

TRANSPLANT-FREE SURVIVAL AMONG PATIENTS WITH HEPATOCELLULAR CARCINOMA MANAGED AT A TERTIARY REFERRAL HOSPITAL IN PERU

Annals of Hepatology
Introduction and Objectives: Peru has one of the highest liver cancer rates in South America, yet limited access to transplantation makes evaluating prognosis through alternative treatments essential.
Mariella Rosalina Huaman Rivera, Diego Francisco Pinto Ruiz, Estefania Liza Baca, Zuly Placido Damian, Javier Diaz Ferrer   +4 more
doaj   +1 more source

Regression of liver fibrosis after HBsAg loss: A prospective matched case–control evaluation using transient elastography and serum enhanced liver fibrosis test

Journal of Gastroenterology and Hepatology, Volume 39, Issue 12, Page 2826-2834, December 2024.
Abstract Background and Aim We assessed the effect of hepatitis B surface antigen (HBsAg) seroclearance (HBsAg‐loss) on liver fibrosis regression in patients with chronic hepatitis B (CHB) infection. Method CHB patients with recent documented HBsAg‐loss were age‐ and gender‐matched with treatment‐naïve HBeAg‐negative CHB infection.
Lung‐Yi Mak, Rex Wan‐Hin Hui, Matthew S. H. Chung, Danny Ka‐Ho Wong, James Fung, Wai‐Kay Seto, Man‐Fung Yuen   +6 more
wiley   +1 more source

Baveno VII Criteria for the Exclusion of Esophageal Varices in a Peruvian Population: Cross-Sectional Study

Revista Colombiana de Gastroenterología
Introduction: Esophageal varices represent one of the main complications in patients with liver cirrhosis. The main objective was to determine the diagnostic performance of the new Baveno VII criteria to exclude the presence of esophageal varices in ...
Celide Campoverde Cueva, Williams Celedonio-Campos, Brayan Campos-Salazar, Rommel Zambrano-Huailla, Karla Alejandra Vizcarra Zevallos, Jorge Garavito-Renteria   +5 more
doaj   +1 more source

Fibroblast growth factor 21 is a hepatokine involved in MASLD progression

United European Gastroenterology Journal, Volume 12, Issue 8, Page 1056-1068, October 2024.
Abstract Aim We aimed to assess the role of FGF21 in metabolic dysfunction‐associated steatotic liver disease (MASLD) at a multi‐scale level. Methods We used human MASLD pathology samples for FGF21 gene expression analyses (qPCR and RNAseq), serum to measure circulating FGF21 levels and DNA for genotyping the FGF21 rs838133 variant in both estimation ...
Rocío Gallego‐Durán, Javier Ampuero, Douglas Maya‐Miles, Helena Pastor‐Ramírez, Rocío Montero‐Vallejo, Jesús Rivera‐Esteban, Leticia Álvarez‐Amor, María Jesús Pareja, María Carmen Rico, Raquel Millán, María José Robles‐Frías, Rocío Aller, Ángela Rojas, Rocío Muñoz‐Hernández, Antonio Gil‐Gómez, Sheila Gato, María García‐Lozano, María Teresa Arias‐Loste, Javier Abad, José Luis Calleja, Raúl J. Andrade, Javier Crespo, Águeda González‐Rodríguez, Carmelo García‐Monzón, Fausto Andreola, Juan Manuel Pericás, Rajiv Jalan, Francisco Martín‐Bermudo, Manuel Romero‐Gómez   +28 more
wiley   +1 more source

Update on ketosis in dairy cattle with major emphasis on subclinical ketosis and abdominal adiposity

Veterinary Medicine and Science, Volume 10, Issue 5, September 2024.
The metabolic changes that occur during the transition period of dairy cows can lead to an imbalance in energy metabolism, resulting in excessive ketone body production. They have detrimental effects on lactational performance, leading to high economic losses on dairy farms.
Pedro Melendez, Manuel Vizcaino Serrano
wiley   +1 more source

CACS, CCTA and mCAD‐LT score in the pre‐transplant assessment of coronary artery disease and the prediction of post‐transplant cardiovascular events

Liver International, Volume 44, Issue 8, Page 1912-1923, August 2024.
Abstract Background The optimal cardiovascular assessment of liver transplant (LT) candidates is unclear. We aimed to evaluate the performance of CT‐based coronary tests (coronary artery calcium score [CACS] and coronary CT angiography [CCTA]) and a modification of the CAD‐LT score (mCAD‐LT, excluding family history of CAD) to diagnose significant ...
Giulia Pagano, Lydia Sastre, Annabel Blasi, Salvatore Brugaletta, Judit Mestres, Julia Martinez‐Ocon, Jose T. Ortiz‐Pérez, Clara Viñals, Susanna Prat‐Gonzàlez, Eva Rivas, Rosario J. Perea, Sergio Rodriguez‐Tajes, África Muxí, Emilio Ortega, Ada Doltra, Pablo Ruiz, Bàrbara Vidal, Graciela Martínez‐Palli, Jordi Colmenero, Gonzalo Crespo   +19 more
wiley   +1 more source

Novel insights into metabolic‐associated steatotic liver disease preclinical models

Liver International, Volume 44, Issue 3, Page 644-662, March 2024.
Abstract Metabolic‐associated steatotic liver disease (MASLD) encompasses a wide spectrum of metabolic conditions associated with an excess of fat accumulation in the liver, ranging from simple hepatic steatosis to cirrhosis and hepatocellular carcinoma.
Rocío Montero‐Vallejo, Douglas Maya‐Miles, Javier Ampuero, Franz Martín, Manuel Romero‐Gómez, Rocío Gallego‐Durán   +5 more
wiley   +1 more source

The role of HBIG in real life for patients undergoing liver transplantation due to HDV‐related cirrhosis

Liver International, Volume 44, Issue 2, Page 279-285, February 2024.
Abstract Recommended post‐liver transplant (LT) prophylaxis in patients with hepatitis delta includes a nucleos(t)ide analogue (NA) and anti‐hepatitis B immunoglobulin (HBIG) indefinitely. We analysed the use of HBIG in real‐life clinical practice and its impact on HBV/HDV recurrence in 174 HDV‐related LT patients from 10 Spanish liver transplant ...
Sergio Rodríguez‐Tajes, María García‐Eliz, Arantxa Caballero Marcos, Isabel Campos‐Varela, Alba Cachero Ros, Carmelo Loinaz, Miguel Á. Gómez Bravo, Manuel Rodríguez‐Perálvarez, Emilio Fabrega, María L. González Diéguez, Carmen Vinaixa, José M. Pascasio, Inmaculada Fernández Vázquez, Carme Baliellas, Lluis Castells, Magdalena Salcedo, Martín Prieto, Gonzalo Crespo, Sabela Lens, Xavier Forns   +19 more
wiley   +1 more source

In vitro analysis of apoptosis in hepatic stellate cells cultured under steatogenic conditions

Annals of Hepatology
Introduction and Objectives: Hepatic stellate cells (HSC) are responsible for the development of fibrosis during chronic liver disease. Cell death is among the most common cellular causes of increased tissue damage. From the different types of cell death,
Adriana Campos-Espinosa, Karla Z. Medina-Ávila, Gabriela Gutiérrez-Reyes, Carolina Guzmán   +3 more
doaj   +1 more source

Indications for treatment in chronic HCV infection

Annals of Hepatology, 2010
HCV Infection is a global burden disease and it is related to the development of progressive liver fibrosis, cirrhosis and hepatocellular carcinoma. At least 80% of the persons that have an acute infection evolve to chronicity.
Milagros Dávalos Moscol
doaj   +1 more source